This inventor holds 1 USPTO granted patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Johan R Johansson: Innovator in Selective Inhibitors
Introduction
Johan R Johansson is a notable inventor recognized for his contributions to the field of pharmaceuticals. He has made significant strides in the development of selective inhibitors, particularly in relation to JAK1 inhibitors. His work is crucial in advancing treatments for various medical conditions.
Latest Patents
Johan holds a patent for "JAK1 Selective Inhibitors." This innovation is pivotal in the ongoing research and development of targeted therapies, showcasing his expertise and commitment to improving healthcare outcomes.
Career Highlights
Johan is currently employed at AstraZeneca UK Limited, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Johan has worked alongside talented colleagues, including Annika Birgitta Margareta Åstrand and Qibin Su. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their shared field.
Conclusion
Johan R Johansson's work in the development of JAK1 selective inhibitors exemplifies his dedication to innovation in pharmaceuticals. His contributions continue to impact the industry positively, paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile